Tao Gong
- Molecular Biology top 1%
- Biomedical Engineering top 0.2%
- Biomaterials top 0.1%
- Pharmaceutical Science top 0.05%
- Immunology top 1%
- Topics
- Nanoparticle-Based Drug Delivery (74 papers)Nanoplatforms for cancer theranostics (53 papers)RNA Interference and Gene Delivery (51 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Tao Gong
463 papers receiving 16.0k citations
Hit Papers
Peers
Comparison fields: 5 of 195
- Molecular Biology 5.2k
- Biomedical Engineering 4.5k
- Biomaterials 4.0k
- Pharmaceutical Science 2.0k
- Immunology 1.7k
Countries citing papers authored by Tao Gong
This map shows the geographic impact of Tao Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Gong more than expected).
Fields of papers citing papers by Tao Gong
This network shows the impact of papers produced by Tao Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Gong. The network helps show where Tao Gong may publish in the future.
Co-authorship network of co-authors of Tao Gong
This figure shows the co-authorship network connecting the top 25 collaborators of Tao Gong. A scholar is included among the top collaborators of Tao Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Gong. Tao Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 13 | |
| 7 | 6 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 29 | |
| 13 | 20 | |
| 14 | 20 | |
| 15 | 50 | |
| 16 | 7 | |
| 17 | 6 | |
| 18 | 32 | |
| 19 | 21 | |
| 20 | 24 |
About Tao Gong
Tao Gong is a scholar working on Pharmaceutical Science, Biomaterials and Periodontics, having authored 477 papers that have together received 16.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (74 papers), Nanoplatforms for cancer theranostics (53 papers) and RNA Interference and Gene Delivery (51 papers). The work is most often cited by research in Pharmaceutical Science (2.0k citations), Biomaterials (4.0k citations) and Polymers and Plastics (1.6k citations). Tao Gong has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Zhirong Zhang, Xun Sun, Yao Fu, Shaobing Zhou, Zhirong Zhang, Xun Sun, Caifeng Deng, Man Li, Sanjun Shi and Qiang Zhao. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.